Press Kits

As a highly focused research-driven biopharmaceutical company, AbbVie takes on the toughest health challenges. But we do more than treat diseases - we aim to make a remarkable impact on people's lives. The AbbVie Press Kit is designed to provide journalists with a broad range of background information on our company. If you are a member of the news media and have questions or need additional information, please contact our Communications Team.

“Blood Cancer, Explained”: Episode 3

Advocacy organizations like the Lymphoma Coalition (LC) and the Leukemia and Lymphoma Society (LLS) serve as a voice for the blood cancer patient community. In episode three of our “Blood Cancer, Explained” roundtable series, we convened LC and LLS for a discussion on the role of global advocacy organizations in raising awareness of lymphoma and supporting patient communities. As part of the conversation, we discussed how patients inspire future innovations in research and treatment for lymphoma and its subtypes.

Subscribe to email alerts

Stay up to date on recent news, articles, and more by subscribing to email alerts for one or more of our news topics.

Learn more



The "Yes" link below will take you out of the AbbVie family of websites.

Links which take you out of the AbbVie worldwide websites are not under the control of AbbVie, and AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply endorsement of the linked site by AbbVie.

The Internet site that you have requested may not be optimized to your screen size.

Do you wish to leave this site?